Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10190948rdf:typepubmed:Citationlld:pubmed
pubmed-article:10190948lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:10190948lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:10190948lifeskim:mentionsumls-concept:C2349179lld:lifeskim
pubmed-article:10190948lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:10190948pubmed:issue4lld:pubmed
pubmed-article:10190948pubmed:dateCreated1999-6-24lld:pubmed
pubmed-article:10190948pubmed:abstractTextIn multiple myeloma (MM) patients treated with conventional chemotherapy, the attainment and duration of a plateau phase seems to affect survival more than the degree of response to initial treatment. The aims of this study are: 1) to analyze within a cohort of previously untreated MM patients the incidence and the duration of the plateau phase; 2) to correlate it with the presenting features; 3) to assess its impact on survival.lld:pubmed
pubmed-article:10190948pubmed:languageenglld:pubmed
pubmed-article:10190948pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10190948pubmed:citationSubsetIMlld:pubmed
pubmed-article:10190948pubmed:statusMEDLINElld:pubmed
pubmed-article:10190948pubmed:monthAprlld:pubmed
pubmed-article:10190948pubmed:issn0390-6078lld:pubmed
pubmed-article:10190948pubmed:authorpubmed-author:BernasconiCClld:pubmed
pubmed-article:10190948pubmed:authorpubmed-author:LazzarinoMMlld:pubmed
pubmed-article:10190948pubmed:authorpubmed-author:CorsoAAlld:pubmed
pubmed-article:10190948pubmed:authorpubmed-author:KlersyCClld:pubmed
pubmed-article:10190948pubmed:authorpubmed-author:ArcainiLLlld:pubmed
pubmed-article:10190948pubmed:authorpubmed-author:NozzaAAlld:pubmed
pubmed-article:10190948pubmed:authorpubmed-author:ZappasodiPPlld:pubmed
pubmed-article:10190948pubmed:issnTypePrintlld:pubmed
pubmed-article:10190948pubmed:volume84lld:pubmed
pubmed-article:10190948pubmed:ownerNLMlld:pubmed
pubmed-article:10190948pubmed:authorsCompleteYlld:pubmed
pubmed-article:10190948pubmed:pagination336-41lld:pubmed
pubmed-article:10190948pubmed:dateRevised2006-4-24lld:pubmed
pubmed-article:10190948pubmed:meshHeadingpubmed-meshheading:10190948...lld:pubmed
pubmed-article:10190948pubmed:meshHeadingpubmed-meshheading:10190948...lld:pubmed
pubmed-article:10190948pubmed:meshHeadingpubmed-meshheading:10190948...lld:pubmed
pubmed-article:10190948pubmed:meshHeadingpubmed-meshheading:10190948...lld:pubmed
pubmed-article:10190948pubmed:meshHeadingpubmed-meshheading:10190948...lld:pubmed
pubmed-article:10190948pubmed:meshHeadingpubmed-meshheading:10190948...lld:pubmed
pubmed-article:10190948pubmed:meshHeadingpubmed-meshheading:10190948...lld:pubmed
pubmed-article:10190948pubmed:meshHeadingpubmed-meshheading:10190948...lld:pubmed
pubmed-article:10190948pubmed:meshHeadingpubmed-meshheading:10190948...lld:pubmed
pubmed-article:10190948pubmed:meshHeadingpubmed-meshheading:10190948...lld:pubmed
pubmed-article:10190948pubmed:meshHeadingpubmed-meshheading:10190948...lld:pubmed
pubmed-article:10190948pubmed:meshHeadingpubmed-meshheading:10190948...lld:pubmed
pubmed-article:10190948pubmed:year1999lld:pubmed
pubmed-article:10190948pubmed:articleTitlePlateau phase in multiple myeloma: an end-point of conventional-dose chemotherapy.lld:pubmed
pubmed-article:10190948pubmed:affiliationInstitute of Hematology, University of Pavia, IRCCS Policlinico San Matteo, 27100 Pavia, Italy. a.corso@smatteo.pv.itlld:pubmed
pubmed-article:10190948pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10190948lld:pubmed